Join us

November

04

at

12:00pm

RSVP

Dice and Bustle have partnered to
promote women in the technology industry

and encourage girls to embark upon a
career in tech in the future.

10

/

19

-

28

,

2017

Made It Awards

More than just an event

12:00pm

-

5:00pm

RSVP

Join us

You're invited to Romper's Made It Awards, an event honoring women who dreamed up a new product, idea, or business and made it a reality —
for themselves, for their kids, and for other women.

Along with our 2017 honorees, we'll be celebrating female entrepreneurship with breakout discussions and cocktails,
and welcoming speakers like Freshly Picked's
Founder and CEO, Susan Petersen.

All attendees will not only have chance to win a GE Appliances washer and dryer and a $5,000 Sally Hansen grant, but will also get a healthy dose of inspiration!

RSVP

The Location

Keynote Speaker

Susan Petersen

CEO & Founder

FRESHLY PICKED

FOUNDER & CEO, Skip & Play

Amy Christine Mabry &
Regina Rae Rice Paquette

Afreen Allam is the founder & CEO of SiNON Therapeutics. A graduate of Duke’s Fuqua School of Business, she has over eight years of research in nanomedicine. Her extensive studies on applications of carbon nanotechnology in drug delivery and bio-imaging led to the patent of the Carbon Dot in 2013. She is a graduate of NC State University with a double major in microbiology and biochemistry and holds a masters degree in finance and banking, she has also conducted research-work at Johns Hopkins. By age 17 Afreen has her first DNA sequence published and filed a patent at age 20. She has presented at numerous biomedical conferences including the Drugs & Diagnostics Conference, Biotech Research Symposium, and National Tech Connect Conference. Afreen has also won the Duke Start-up challenge award and NC Idea grants.

FOUNDER & CEO, Werk

Blair Fillingham

Afreen Allam is the founder & CEO of SiNON Therapeutics. A graduate of Duke’s Fuqua School of Business, she has over eight years of research in nanomedicine. Her extensive studies on applications of carbon nanotechnology in drug delivery and bio-imaging led to the patent of the Carbon Dot in 2013. She is a graduate of NC State University with a double major in microbiology and biochemistry and holds a masters degree in finance and banking, she has also conducted research-work at Johns Hopkins. By age 17 Afreen has her first DNA sequence published and filed a patent at age 20. She has presented at numerous biomedical conferences including the Drugs & Diagnostics Conference, Biotech Research Symposium, and National Tech Connect Conference. Afreen has also won the Duke Start-up challenge award and NC Idea grants.

FOUNDER & CEO, MTRNL

Blair Fillingham

Afreen Allam is the founder & CEO of SiNON Therapeutics. A graduate of Duke’s Fuqua School of Business, she has over eight years of research in nanomedicine. Her extensive studies on applications of carbon nanotechnology in drug delivery and bio-imaging led to the patent of the Carbon Dot in 2013. She is a graduate of NC State University with a double major in microbiology and biochemistry and holds a masters degree in finance and banking, she has also conducted research-work at Johns Hopkins. By age 17 Afreen has her first DNA sequence published and filed a patent at age 20. She has presented at numerous biomedical conferences including the Drugs & Diagnostics Conference, Biotech Research Symposium, and National Tech Connect Conference. Afreen has also won the Duke Start-up challenge award and NC Idea grants.

FOUNDER & CEO, Halloween Holly

Cara Via

Afreen Allam is the founder & CEO of SiNON Therapeutics. A graduate of Duke’s Fuqua School of Business, she has over eight years of research in nanomedicine. Her extensive studies on applications of carbon nanotechnology in drug delivery and bio-imaging led to the patent of the Carbon Dot in 2013. She is a graduate of NC State University with a double major in microbiology and biochemistry and holds a masters degree in finance and banking, she has also conducted research-work at Johns Hopkins. By age 17 Afreen has her first DNA sequence published and filed a patent at age 20. She has presented at numerous biomedical conferences including the Drugs & Diagnostics Conference, Biotech Research Symposium, and National Tech Connect Conference. Afreen has also won the Duke Start-up challenge award and NC Idea grants.

FOUNDER & CEO, Bash & Sass

Irene Lee

Afreen Allam is the founder & CEO of SiNON Therapeutics. A graduate of Duke’s Fuqua School of Business, she has over eight years of research in nanomedicine. Her extensive studies on applications of carbon nanotechnology in drug delivery and bio-imaging led to the patent of the Carbon Dot in 2013. She is a graduate of NC State University with a double major in microbiology and biochemistry and holds a masters degree in finance and banking, she has also conducted research-work at Johns Hopkins. By age 17 Afreen has her first DNA sequence published and filed a patent at age 20. She has presented at numerous biomedical conferences including the Drugs & Diagnostics Conference, Biotech Research Symposium, and National Tech Connect Conference. Afreen has also won the Duke Start-up challenge award and NC Idea grants.

FOUNDER & CEO, Kaike

Keli Smith

Afreen Allam is the founder & CEO of SiNON Therapeutics. A graduate of Duke’s Fuqua School of Business, she has over eight years of research in nanomedicine. Her extensive studies on applications of carbon nanotechnology in drug delivery and bio-imaging led to the patent of the Carbon Dot in 2013. She is a graduate of NC State University with a double major in microbiology and biochemistry and holds a masters degree in finance and banking, she has also conducted research-work at Johns Hopkins. By age 17 Afreen has her first DNA sequence published and filed a patent at age 20. She has presented at numerous biomedical conferences including the Drugs & Diagnostics Conference, Biotech Research Symposium, and National Tech Connect Conference. Afreen has also won the Duke Start-up challenge award and NC Idea grants.

FOUNDER & CEO, Milk Expressed

Kristy Catsouphes

Afreen Allam is the founder & CEO of SiNON Therapeutics. A graduate of Duke’s Fuqua School of Business, she has over eight years of research in nanomedicine. Her extensive studies on applications of carbon nanotechnology in drug delivery and bio-imaging led to the patent of the Carbon Dot in 2013. She is a graduate of NC State University with a double major in microbiology and biochemistry and holds a masters degree in finance and banking, she has also conducted research-work at Johns Hopkins. By age 17 Afreen has her first DNA sequence published and filed a patent at age 20. She has presented at numerous biomedical conferences including the Drugs & Diagnostics Conference, Biotech Research Symposium, and National Tech Connect Conference. Afreen has also won the Duke Start-up challenge award and NC Idea grants.

FOUNDER & CEO, Love Lane Designs

Lane Huerta

Afreen Allam is the founder & CEO of SiNON Therapeutics. A graduate of Duke’s Fuqua School of Business, she has over eight years of research in nanomedicine. Her extensive studies on applications of carbon nanotechnology in drug delivery and bio-imaging led to the patent of the Carbon Dot in 2013. She is a graduate of NC State University with a double major in microbiology and biochemistry and holds a masters degree in finance and banking, she has also conducted research-work at Johns Hopkins. By age 17 Afreen has her first DNA sequence published and filed a patent at age 20. She has presented at numerous biomedical conferences including the Drugs & Diagnostics Conference, Biotech Research Symposium, and National Tech Connect Conference. Afreen has also won the Duke Start-up challenge award and NC Idea grants.

FOUNDER & CEO, Social Media Influencer

Latonya Yvette

Afreen Allam is the founder & CEO of SiNON Therapeutics. A graduate of Duke’s Fuqua School of Business, she has over eight years of research in nanomedicine. Her extensive studies on applications of carbon nanotechnology in drug delivery and bio-imaging led to the patent of the Carbon Dot in 2013. She is a graduate of NC State University with a double major in microbiology and biochemistry and holds a masters degree in finance and banking, she has also conducted research-work at Johns Hopkins. By age 17 Afreen has her first DNA sequence published and filed a patent at age 20. She has presented at numerous biomedical conferences including the Drugs & Diagnostics Conference, Biotech Research Symposium, and National Tech Connect Conference. Afreen has also won the Duke Start-up challenge award and NC Idea grants.

FOUNDER & CEO, CHOOZE

Sharon Blumberg

Afreen Allam is the founder & CEO of SiNON Therapeutics. A graduate of Duke’s Fuqua School of Business, she has over eight years of research in nanomedicine. Her extensive studies on applications of carbon nanotechnology in drug delivery and bio-imaging led to the patent of the Carbon Dot in 2013. She is a graduate of NC State University with a double major in microbiology and biochemistry and holds a masters degree in finance and banking, she has also conducted research-work at Johns Hopkins. By age 17 Afreen has her first DNA sequence published and filed a patent at age 20. She has presented at numerous biomedical conferences including the Drugs & Diagnostics Conference, Biotech Research Symposium, and National Tech Connect Conference. Afreen has also won the Duke Start-up challenge award and NC Idea grants.

12:00 PM

Welcome Lunch

1:00 PM

Keynote Address:
Susan Petersen, CEO & Founder,
Freshly Picked

1:15 PM

Sally Hansen Presents
Hard As Nails:
Want To Be Self-Made?
Make Hard Decisions.

2:15 PM

Breakout Discussion #1

3:00 PM

Breakout Discussion #2

3:30 PM

Cocktail Hour

3:35 PM

Sally Hansen Hard As Nails Grant Presentation

3:45 PM

Awards Presentation / Closing Remarks

4:00 PM

Networking and Drinks

Our Sponsors

Event is 21+ Each RSVP is good for one entry

Please Drink Responsibly.

#MadeITAwards